V, totaling more than 2,800 individuals. The first cohort consisted of patients included in three data sources: a) four sites of the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS), a database of real-time clinical care and laboratory data; b) the San Francisco Men's Health Study (SFMHS) and the Research in Access to Care for the Homeless Cohort (REACH). This cohort included approximately 12% female and 35% non- Caucasian participants. The second cohort, which the investigators used to validate their findings in the first group, included participants in the Multicenter AIDS Cohort Study, a long-standing federally funded study composed largely of Caucasian men who have sex with men.
The investigators sought to estimate how much of the person-to-person variation in the rate of CD4 cell loss could be accounted for on the basis of each patient's initial viral load, in an attempt to reproduce more closely the situation that a physician would encounter in clinical practice, where a patient presents with an initial set of laboratory results and the clinician must try to predict how quickly that person's CD4 cell count will reach the danger level at which treatment for HIV becomes most critical. Current clinical practice, based on previous work from other groups, is to focus on both the current CD4 count and the viral load to estimate how rapidly a person's CD4 cell count will decrease. This approach is based on comparisons of the average rate of CD4 cell loss among groups of patients with roughly similar viral loads, which indicate that generally speaking, patients with higher viral loads will tend to experience more rapid CD4 cell loss than patients with lower viral loads. Until now, however, there had been no attempt to quantify how well this observation held when considering the estimated rate of CD4 cell loss for each individual patient.
Using sophisticated statistical modeling, the researchers found that only 4-6% of aPage: 1 2 3 Related biology news :1
Source:University Hospitals of Cleveland
. Bioartificial kidney under study at MCG2
. W.M. Keck Foundation funds study of friendly microbes3
. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study4
. Genome-wide mouse study yields link to human leukemia5
. Clam embryo study shows pollutant mixture adversely affects nerve cell development6
. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows7
. Same mutation aided evolution in many fish species, Stanford study finds8
. Sequencing of marine bacterium will help study of cell communication9
. Genetically modified rice in China benefits farmers health, study finds10
. A new study examines how shared pathogens affect host populations11
. NYU study reveals how brains immune system fights viral encephalitis